Chronic Disease Management Market Size & Share by 2022-2028

Global Chronic Disease Management Market Size, Share & Industry Trends Analysis Report By Type (Solutions and Services), By End User (Healthcare Providers, Healthcare Payers and Others), By Disease Type, By Regional Outlook and Forecast, 2022 - 2028

Published Date: August-2022 | Number of Pages: 232 | Format: PDF | Report ID: KBV-19600

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Chronic Disease Management Market, by Type
1.4.2 Global Chronic Disease Management Market, by End User
1.4.3 Global Chronic Disease Management Market, by Disease Type
1.4.4 Global Chronic Disease Management Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep – 2022, May) Leading Players

Chapter 4. Global Chronic Disease Management Market by Type
4.1 Global Solutions Market by Region
4.2 Global Services Market by Region

Chapter 5. Global Chronic Disease Management Market by End User
5.1 Global Healthcare Providers Market by Region
5.2 Global Healthcare Payers Market by Region
5.3 Global Others Market by Region

Chapter 6. Global Chronic Disease Management Market by Disease Type
6.1 Global Diabetes Market by Region
6.2 Global Cardiovascular diseases Market by Region
6.3 Global Asthma Market by Region
6.4 Global Chronic obstructive pulmonary disorders Market by Region
6.5 Global Cancer Market by Region
6.6 Global Others Market by Region

Chapter 7. Global Chronic Disease Management Market by Region
7.1 North America Chronic Disease Management Market
7.1.1 North America Chronic Disease Management Market by Type
7.1.1.1 North America Solutions Market by Country
7.1.1.2 North America Services Market by Country
7.1.2 North America Chronic Disease Management Market by End User
7.1.2.1 North America Healthcare Providers Market by Country
7.1.2.2 North America Healthcare Payers Market by Country
7.1.2.3 North America Others Market by Country
7.1.3 North America Chronic Disease Management Market by Disease Type
7.1.3.1 North America Diabetes Market by Country
7.1.3.2 North America Cardiovascular diseases Market by Country
7.1.3.3 North America Asthma Market by Country
7.1.3.4 North America Chronic obstructive pulmonary disorders Market by Country
7.1.3.5 North America Cancer Market by Country
7.1.3.6 North America Others Market by Country
7.1.4 North America Chronic Disease Management Market by Country
7.1.4.1 US Chronic Disease Management Market
7.1.4.1.1 US Chronic Disease Management Market by Type
7.1.4.1.2 US Chronic Disease Management Market by End User
7.1.4.1.3 US Chronic Disease Management Market by Disease Type
7.1.4.2 Canada Chronic Disease Management Market
7.1.4.2.1 Canada Chronic Disease Management Market by Type
7.1.4.2.2 Canada Chronic Disease Management Market by End User
7.1.4.2.3 Canada Chronic Disease Management Market by Disease Type
7.1.4.3 Mexico Chronic Disease Management Market
7.1.4.3.1 Mexico Chronic Disease Management Market by Type
7.1.4.3.2 Mexico Chronic Disease Management Market by End User
7.1.4.3.3 Mexico Chronic Disease Management Market by Disease Type
7.1.4.4 Rest of North America Chronic Disease Management Market
7.1.4.4.1 Rest of North America Chronic Disease Management Market by Type
7.1.4.4.2 Rest of North America Chronic Disease Management Market by End User
7.1.4.4.3 Rest of North America Chronic Disease Management Market by Disease Type
7.2 Europe Chronic Disease Management Market
7.2.1 Europe Chronic Disease Management Market by Type
7.2.1.1 Europe Solutions Market by Country
7.2.1.2 Europe Services Market by Country
7.2.2 Europe Chronic Disease Management Market by End User
7.2.2.1 Europe Healthcare Providers Market by Country
7.2.2.2 Europe Healthcare Payers Market by Country
7.2.2.3 Europe Others Market by Country
7.2.3 Europe Chronic Disease Management Market by Disease Type
7.2.3.1 Europe Diabetes Market by Country
7.2.3.2 Europe Cardiovascular diseases Market by Country
7.2.3.3 Europe Asthma Market by Country
7.2.3.4 Europe Chronic obstructive pulmonary disorders Market by Country
7.2.3.5 Europe Cancer Market by Country
7.2.3.6 Europe Others Market by Country
7.2.4 Europe Chronic Disease Management Market by Country
7.2.4.1 Germany Chronic Disease Management Market
7.2.4.1.1 Germany Chronic Disease Management Market by Type
7.2.4.1.2 Germany Chronic Disease Management Market by End User
7.2.4.1.3 Germany Chronic Disease Management Market by Disease Type
7.2.4.2 UK Chronic Disease Management Market
7.2.4.2.1 UK Chronic Disease Management Market by Type
7.2.4.2.2 UK Chronic Disease Management Market by End User
7.2.4.2.3 UK Chronic Disease Management Market by Disease Type
7.2.4.3 France Chronic Disease Management Market
7.2.4.3.1 France Chronic Disease Management Market by Type
7.2.4.3.2 France Chronic Disease Management Market by End User
7.2.4.3.3 France Chronic Disease Management Market by Disease Type
7.2.4.4 Russia Chronic Disease Management Market
7.2.4.4.1 Russia Chronic Disease Management Market by Type
7.2.4.4.2 Russia Chronic Disease Management Market by End User
7.2.4.4.3 Russia Chronic Disease Management Market by Disease Type
7.2.4.5 Spain Chronic Disease Management Market
7.2.4.5.1 Spain Chronic Disease Management Market by Type
7.2.4.5.2 Spain Chronic Disease Management Market by End User
7.2.4.5.3 Spain Chronic Disease Management Market by Disease Type
7.2.4.6 Italy Chronic Disease Management Market
7.2.4.6.1 Italy Chronic Disease Management Market by Type
7.2.4.6.2 Italy Chronic Disease Management Market by End User
7.2.4.6.3 Italy Chronic Disease Management Market by Disease Type
7.2.4.7 Rest of Europe Chronic Disease Management Market
7.2.4.7.1 Rest of Europe Chronic Disease Management Market by Type
7.2.4.7.2 Rest of Europe Chronic Disease Management Market by End User
7.2.4.7.3 Rest of Europe Chronic Disease Management Market by Disease Type
7.3 Asia Pacific Chronic Disease Management Market
7.3.1 Asia Pacific Chronic Disease Management Market by Type
7.3.1.1 Asia Pacific Solutions Market by Country
7.3.1.2 Asia Pacific Services Market by Country
7.3.2 Asia Pacific Chronic Disease Management Market by End User
7.3.2.1 Asia Pacific Healthcare Providers Market by Country
7.3.2.2 Asia Pacific Healthcare Payers Market by Country
7.3.2.3 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Chronic Disease Management Market by Disease Type
7.3.3.1 Asia Pacific Diabetes Market by Country
7.3.3.2 Asia Pacific Cardiovascular diseases Market by Country
7.3.3.3 Asia Pacific Asthma Market by Country
7.3.3.4 Asia Pacific Chronic obstructive pulmonary disorders Market by Country
7.3.3.5 Asia Pacific Cancer Market by Country
7.3.3.6 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Chronic Disease Management Market by Country
7.3.4.1 China Chronic Disease Management Market
7.3.4.1.1 China Chronic Disease Management Market by Type
7.3.4.1.2 China Chronic Disease Management Market by End User
7.3.4.1.3 China Chronic Disease Management Market by Disease Type
7.3.4.2 Japan Chronic Disease Management Market
7.3.4.2.1 Japan Chronic Disease Management Market by Type
7.3.4.2.2 Japan Chronic Disease Management Market by End User
7.3.4.2.3 Japan Chronic Disease Management Market by Disease Type
7.3.4.3 India Chronic Disease Management Market
7.3.4.3.1 India Chronic Disease Management Market by Type
7.3.4.3.2 India Chronic Disease Management Market by End User
7.3.4.3.3 India Chronic Disease Management Market by Disease Type
7.3.4.4 South Korea Chronic Disease Management Market
7.3.4.4.1 South Korea Chronic Disease Management Market by Type
7.3.4.4.2 South Korea Chronic Disease Management Market by End User
7.3.4.4.3 South Korea Chronic Disease Management Market by Disease Type
7.3.4.5 Singapore Chronic Disease Management Market
7.3.4.5.1 Singapore Chronic Disease Management Market by Type
7.3.4.5.2 Singapore Chronic Disease Management Market by End User
7.3.4.5.3 Singapore Chronic Disease Management Market by Disease Type
7.3.4.6 Malaysia Chronic Disease Management Market
7.3.4.6.1 Malaysia Chronic Disease Management Market by Type
7.3.4.6.2 Malaysia Chronic Disease Management Market by End User
7.3.4.6.3 Malaysia Chronic Disease Management Market by Disease Type
7.3.4.7 Rest of Asia Pacific Chronic Disease Management Market
7.3.4.7.1 Rest of Asia Pacific Chronic Disease Management Market by Type
7.3.4.7.2 Rest of Asia Pacific Chronic Disease Management Market by End User
7.3.4.7.3 Rest of Asia Pacific Chronic Disease Management Market by Disease Type
7.4 LAMEA Chronic Disease Management Market
7.4.1 LAMEA Chronic Disease Management Market by Type
7.4.1.1 LAMEA Solutions Market by Country
7.4.1.2 LAMEA Services Market by Country
7.4.2 LAMEA Chronic Disease Management Market by End User
7.4.2.1 LAMEA Healthcare Providers Market by Country
7.4.2.2 LAMEA Healthcare Payers Market by Country
7.4.2.3 LAMEA Others Market by Country
7.4.3 LAMEA Chronic Disease Management Market by Disease Type
7.4.3.1 LAMEA Diabetes Market by Country
7.4.3.2 LAMEA Cardiovascular diseases Market by Country
7.4.3.3 LAMEA Asthma Market by Country
7.4.3.4 LAMEA Chronic obstructive pulmonary disorders Market by Country
7.4.3.5 LAMEA Cancer Market by Country
7.4.3.6 LAMEA Others Market by Country
7.4.4 LAMEA Chronic Disease Management Market by Country
7.4.4.1 Brazil Chronic Disease Management Market
7.4.4.1.1 Brazil Chronic Disease Management Market by Type
7.4.4.1.2 Brazil Chronic Disease Management Market by End User
7.4.4.1.3 Brazil Chronic Disease Management Market by Disease Type
7.4.4.2 Argentina Chronic Disease Management Market
7.4.4.2.1 Argentina Chronic Disease Management Market by Type
7.4.4.2.2 Argentina Chronic Disease Management Market by End User
7.4.4.2.3 Argentina Chronic Disease Management Market by Disease Type
7.4.4.3 UAE Chronic Disease Management Market
7.4.4.3.1 UAE Chronic Disease Management Market by Type
7.4.4.3.2 UAE Chronic Disease Management Market by End User
7.4.4.3.3 UAE Chronic Disease Management Market by Disease Type
7.4.4.4 Saudi Arabia Chronic Disease Management Market
7.4.4.4.1 Saudi Arabia Chronic Disease Management Market by Type
7.4.4.4.2 Saudi Arabia Chronic Disease Management Market by End User
7.4.4.4.3 Saudi Arabia Chronic Disease Management Market by Disease Type
7.4.4.5 South Africa Chronic Disease Management Market
7.4.4.5.1 South Africa Chronic Disease Management Market by Type
7.4.4.5.2 South Africa Chronic Disease Management Market by End User
7.4.4.5.3 South Africa Chronic Disease Management Market by Disease Type
7.4.4.6 Nigeria Chronic Disease Management Market
7.4.4.6.1 Nigeria Chronic Disease Management Market by Type

7.4.4.6.2 Nigeria Chronic Disease Management Market by End User
7.4.4.6.3 Nigeria Chronic Disease Management Market by Disease Type
7.4.4.7 Rest of LAMEA Chronic Disease Management Market
7.4.4.7.1 Rest of LAMEA Chronic Disease Management Market by Type
7.4.4.7.2 Rest of LAMEA Chronic Disease Management Market by End User
7.4.4.7.3 Rest of LAMEA Chronic Disease Management Market by Disease Type

Chapter 8. Company Profiles
8.1 Infosys Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 ExlService Holdings, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.3 Health Catalyst, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 AllScripts Healthcare Solutions, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expenses
8.5 Koninklijke Philips N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.5.4 Approvals and Trials:
8.6 Cognizant Technology Solutions Corporation
8.6.1 Company overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.5 SWOT Analysis
8.7 Casenet, LLC (Zyter, Inc.)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Cedar Gate Technologies
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 Clinical Excellence, Inc.
8.9.1 Company Overview
8.10. Altruista Health, Inc. (HealthEdge Software, Inc.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:

Purchase Report

 3600
 4320
 6048

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities